RAPHAS’s Acropass Trouble Cure Continues to Transform Skincare Regimens

Share This Post

ACROPASS logo

Trouble Cure_Acropass

Acropass Trouble Cure Microcone Patch

Acropass Trouble Cure Microcone Spot Patch

Acropass Trouble Cure Microcone Patch

SEOUL, SOUTH KOREA, January 12, 2024 /EINPresswire.com/ — RAPHAS’s flagship product, Acropass Trouble Cure, is revolutionizing the treatment of skin troubles with its advanced microneedle technology, patented globally. This innovative patch system delivers a potent combination of hyaluronic acid, niacinamide, and oligopeptide-76 deep into the skin using microneedles as fine as one-third the thickness of a hair strand.

Proven by rigorous clinical trials at the Korean Dermatological Science Institute, Acropass Trouble Cure has shown a 64.4% improvement in trouble severity and a 59.8% reduction in sebum production. 90% of the trial participants witnessed significant improvements, affirming its effectiveness for acne-prone skin.

Designed with safety in mind, Acropass Trouble Cure is formulated without chemical additives, making it suitable for sensitive skin.

Each package includes sterilized patches and alcohol swabs, ensuring a convenient and hygienic application.

As RAPHAS continues to extend its global footprint, Acropass Trouble Cure is now a staple in the American skincare market, available at ‘T.J.Maxx’ stores across North America. The brand’s presence in Singapore’s ‘Guardian’ drugstores and expansion into China’s Qingdao Kingking Group distribution channels further exemplify RAPHAS’s commitment to meeting the growing demands for dermatocosmetic solutions worldwide.

“Acropass Trouble Cure is already a trusted name in skincare, backed by our cutting-edge microneedle technology,” says Hyunwoo Park, Head of the Cosmetics Division at RAPHAS. “We are proud to deliver this product to consumers globally, harnessing the power of our innovation for visible skin improvements.”

Next month, RAPHAS is excited to expand its skincare line with the launch of the TGI Patch in the U.S., a new addition specifically designed for acne-prone skin, leveraging our proprietary microneedle technology.

Acropass, TGI Patch
Raphas
email us here

Article originally published on www.einpresswire.com as RAPHAS’s Acropass Trouble Cure Continues to Transform Skincare Regimens

Related Posts

Kids Get in Free: High School Baseball National Championship Series, Presented by Stinger Sports, Set for June 27-30 at Charles Schwab Field, Omaha, NE

The best-of-the-best high school baseball players from across the country are coming to Omaha. See the stars of tomorrow battle it out on the biggest stage. ...

FTC Data Shows Major Increases in Cash Payments to Government Impersonation Scammers

New Federal Trade Commission data reveals that government impersonation...

Introducing $UTHX, the Preeminent Metaverse Token on the Solana Blockchain

Utherverse (Utherverse.io) announces the August 2024 launch of $UTHX Utherverse Utherverse LOS ANGELES, June 14, ...

SWTHZ (SweatHouz) Appoints Dr. Susanna Søberg, PhD as Lead Science and Education Advisor

ATLANTA, June 13, 2024 (Newswire.com) - SWTHZ, the leader in boutique wellness and contrast therapy, is excited to announce the appointment of Dr. Susanna Søb...

Two Leading Student Transportation Technology Groups Announce Integration to Serve Joint Customers

Bytecurve and BusPlanner integration delivers opportunity for improved performance for hundreds of school bus fleets ...
green agriculture project
- Part of VUGA Media group -best seo company